Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-18

Clinical Trial Update: Efficacy of Using Solum IV and BMC With GFC in TLIF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Solum IV and bone marrow concentrate with growth factor concentrate in TLIF for degenerative spine conditions has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bone Marrow Concentrate with Growth Factor Concentrate
  • Solum IV

Snippet

Sponsor: Seton Healthcare Family | Conditions: Degenerative Disc Disease, Isthmic-lytic Spondylolisthesis | Phase 4 | Status: WITHDRAWN